Healthcare angels are easier to find through dedicated groups than through a ranked list, because no public ranking of individuals exists. Named groups include angelMD, Angels Santé, Angels4Health, HaloHealth and MDAngels. The Angel Capital Association says its health and life-science categories took nearly 47% of reported US angel dollars in 2025.
This guide covers the groups whose members invest in care delivery, digital health and health services. The science-stage groups for therapeutics and research tools are on the biotech angels page. Below are the groups that publish who they are, then how much money is moving and what physician investors say they bring.
Which groups of angels focus on healthcare?
In alphabetical order, with what each says about itself:
angelMD (United States). Medical Economics reported in April 2018 that angelMD is a Seattle-based crowdfunding platform led by CEO Tobin Arthur that connects accredited investors, mostly physicians, with digital health startups. Physicians are asked, though it is optional, to share their practice experience with the startups. The article is from 2018, so the platform's current structure may differ.
Angels Santé (France). Its site calls it Europe's leading network of business angels dedicated to healthcare, supporting biotech, medtech and e-health start-ups since 2008. It runs pitches and events for members. In France Angels' 2024 report it ranks fifth among all French angel networks, with €2.07 million invested.
Angels4Health. A network of more than 30 private angels (as of October 2026) focused on early-stage life science and healthcare, including digital health and medtech. Members are former entrepreneurs, physicians and senior executives. It holds virtual pitch events on the first Thursday of each month, and says it does not manage a fund or appear on cap tables, so members invest individually.
HaloHealth (Canada). Its homepage calls it a Canadian physician and dentist exclusive angel investment group that advises, connects and invests in healthcare ventures, and lists 51 invested startups and five exits as of October 2026. Entrevestor reported in October 2021 that it describes itself as Canada's first physician angel group, began in early 2020, and had partnered with Eastern Health in Newfoundland and Labrador to give startups access to physician expertise and a health system for user testing and trials.
MDAngels (United States). The same 2018 Medical Economics article describes a Chicago network of more than two dozen physicians, founded by Jay Joshi, that meets quarterly and had invested an average of $85,000 in a handful of startups. Joshi told the magazine he refers the companies to hospitals and nursing homes he knows.
What do physician investors say they bring?
The clearest public statements come from the 2018 Medical Economics piece and the Eastern Health partnership. Medical Economics lists industry knowledge and insight into how practices work, referral connections to hospitals and nursing homes, the ability to test an idea with colleagues, and critical scrutiny that finds weaknesses in a plan. angelMD's CEO argued that investors do better when they back what they know. In the Entrevestor report, Eastern Health's research and innovation director said that many healthcare products are physician-led, and that other physicians grasp their relevance, while health care can be a black box for anyone outside the system.
None of these sources measures returns, and none says that physician-run groups outperform other angels. They describe what members offer a startup, not what they earn.
How much angel money goes into healthcare?
In the US, the Angel Capital Association's July 2026 report says medical devices, pharma and therapeutics, digital health and diagnostics together made up nearly 47% of reported angel dollars in 2025, up from 37% in 2024 and 31% in 2023. Reported angel investment rose 12% to $491.3 million, and groups wrote larger cheques into fewer companies.
In Europe, EBAN's data shows health at 12% of angel euros in 2024 and the second-largest sector by number of rounds, with 593. France Angels lists health at 30% in France, behind digital at 36%.
Rock Health tracks digital health venture funding separately. It says startups raised $7.4 billion across 244 deals in the first half of 2026, against $6.4 billion in the first half of 2025, with mega deals of $100 million or more taking 45% of capital. Close to half of the capital went into a small number of very large rounds.
How do these groups run their process?
The groups publish different routes. Angels4Health runs monthly virtual pitch events, Angels Santé works through pitches and events for its members, and MDAngels meets quarterly. HaloHealth's homepage says it welcomes all physicians and dentists who want to join, and angelMD works as an online platform for accredited investors.
For deeper background, see the healthcare and biotech investing guide, the digital health guide and the France guide. For doctors who want to invest, see angel investing for doctors and lawyers and how to join an angel group. The wider angel investing section has more.
Frequently Asked Questions
Q:How much of angel investing goes to healthcare?
In the Angel Capital Association's 2026 report, medical devices, pharma and therapeutics, digital health and diagnostics took nearly 47% of reported US angel dollars in 2025. In EBAN's 2024 European data, health took 12% of angel euros.
Q:Do healthcare angels need a medical background?
Not as a rule, but several groups lean that way. HaloHealth is physician and dentist exclusive, angelMD attracts mostly physicians, and Angels4Health says its members are former entrepreneurs, physicians or senior business leaders. Membership terms differ by group.
Q:What check size do healthcare angels write?
There is no single public figure. Medical Economics reported in 2018 that MDAngels had invested an average of $85,000 in a handful of startups. The ACA report adds that angel groups are writing larger cheques into fewer companies.
Q:Is digital health funding recovering?
Rock Health reports $7.4 billion in the first half of 2026, up from $6.4 billion a year earlier. It also says nearly half the money went into mega deals, so early-stage founders still compete for a smaller share.